IDS Member

Professor Chui obtained her PhD degree from the Department of Pharmacology and Pharmacy at HKU in 2017. She had led the design and analysis of studies using electronic health records from multi-databases (including Hong Kong, Taiwan, United Kingdom, Sweden, and Australia). She was a visiting scholar (PhD exchange student) at the London School of Hygiene and Tropical Medicines in United Kingdom. She completed her post-doctoral training in the School of Public Health at HKU in 2019.

Professor Chui aims to utilize Big Data from multi-regional/national large healthcare databases and that collected in the community to improve public health. Her current research focuses on cardiovascular disease risk prediction and evaluation using artificial intelligence (AI), Big Data for antimicrobial resistance surveillance, and improving care of people living with dementia. Professor Chui is a Co-principal investigator of AI and Pharmaceuticals in Non-Communicable Diseases at the Laboratory of Data Discovery for Health (D²4H). Professor Chui is also the convener and active member of NeuroGEN (Neurological and Mental Health Global Epidemiology Network), and one of the lead researchers in the CARE Programme, a comprehensive surveillance programme to monitor known and potential adverse events of COVID-19 vaccines.

She is the Principal investigator of a cardiovascular risk prediction model designed for Hong Kong population – P-CARDIAC (Personalised – CARdiovascular DIsease risk Assessment for Chinese) which her work is extensively covered by the media. Professor Chui has an h-index (Scopus) of 21 and has published more than 80 articles in peer-reviewed journals such as The Lancet Infectious Disease, Annals of Internal Medicine, BMJ, JAMA Internal Medicine, and Journal of the American College of Cardiology.